Abpro Holdings, Inc.
ABPO- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001893219
No open-market purchases or sales by Abpro Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesABPWW
Q4 2025 vs. Q3 2025
How the institutions holding Abpro Holdings, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 0 | 9 | +9 |
| Shares | 0 | 46.5K | +46.5K |
| Value | $0 | $196.9K | +$196.9K |
New holders (9)
Institutions that held Abpro Holdings, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 20,084 | $85.0K | 0.00% |
| Goldman Sachs Group Inc | 12,383 | $52.4K | 0.00% |
| Geode Capital Management, LLC | 10,785 | $45.6K | 0.00% |
| LMR Partners LLP | 2,084 | $8.81K | 0.00% |
| Tower Research Capital LLC (TRC) | 436 | $1.84K | 0.00% |
| Clear Street Group Inc. | 436 | $1.84K | 0.00% |
| UBS Group AG | 315 | $1.33K | 0.00% |
| Bank of America Corp | 15 | $64 | 0.00% |
| SBI Securities Co., Ltd. | 5 | $21 | 0.00% |
Sold out (0)
Institutions that held Abpro Holdings, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
None.